Peripheral vasodilators
Granskad av Dr Philippa Vincent, MRCGPSenast uppdaterad av Dr Surangi Mendis, MRCGPLast updated 28 sept 2023
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ljudversion
- Add to preferred sources on Google
Peripheral vasodilators are medicines that are used to treat conditions that affect blood vessels in outer (peripheral) parts of the body such as the arms and legs. For example, they are used to treat peripheral arterial disease and Raynaud's phenomenon. They ease the symptoms of these conditions by dilating the blood vessels, preventing them from becoming narrower (constricting). These medicines are usually only prescribed after self-help measures have been tried and symptoms do not improve.
At a glance
Peripheral vasodilators are medicines that widen blood vessels in the limbs.
They are used to treat peripheral arterial disease and Raynaud's phenomenon.
Different types of these medicines are available to prescribe, such as nifedipine and naftidrofuryl.
They are usually prescribed if other self-help measures have not improved symptoms.
Possible side-effects include headache, flushing, or stomach problems.
You need a prescription from a doctor to get these medicines.

Osäker på att blanda mediciner?
Kontrollera möjliga interaktioner mellan läkemedel, kosttillskott och livsmedel innan du tar dem tillsammans.
I den här artikeln:
Video picks for Heart and blood medicines
Fortsätt läsa nedan
What are peripheral vasodilators?
Peripheral vasodilators are used in peripheral arterial disease (PAD) and intermittent claudication to try to open up (dilate) the arteries; this helps to increase the distance you can walk before pain develops.
In Raynaud's phenomenon they are used to dilate the small blood vessels and prevent them from constricting. This helps to maintain the blood supply to the fingers, etc.
The peripheral vasodilator medications all reduce 'vascular resistance'. This is the resistance that should be overcome to push blood through the vessels in the limbs, to allow blood to flow.
There are a number of different peripheral vasodilator drugs. They include, nifedipine, cilostazol, moxisylyte, naftidrofuryl and pentoxifylline. These medicines are available as tablets and capsules and each one may have various other brand names (see Generic Medicines vs Brand Names).
Inositol nicotinate and pentoxifylline are not considered effective for PAD. Pentoxifylline and moxisylyte are not considered effective for Raynaud's phenomenon.
When are peripheral vasodilators usually prescribed?
Tillbaka till innehållIn cases of intermittent claudication, a vasodilator is usually only prescribed if self-help measures such as exercise have not improved the symptoms and surgery is not being considered.
However, they do not work in all cases. Therefore, there is no point in continuing with these medicines if an improvement in symptoms is not seen within a few weeks. If symptoms do not improve, stopping treatment would usually be advised. If symptoms improve, the treatment can be continued. The treatment is usually reviewed regularly to ensure that it is still being of benefit.
In Raynaud's phenomenon, nifedipine is usually only prescribed after self-help measures (such as keeping the whole body warm, including the hands and feet, and stopping smoking) have been tried and the symptoms have not improved. Usually a short course of nifedipine is prescribed to begin with to see if it works..
Fortsätt läsa nedan
How do peripheral vasodilators work?
Tillbaka till innehållPeripheral vasodilators work in slightly different ways to one another.
Cilostazol and inositol nicotinate work by widening the arteries that supply blood to the legs. Cilostazol also improves circulation by keeping platelets in the blood from sticking together and clotting.
Naftidrofuryl works by blocking the effects of a chemical called serotonin on the blood vessels. As a serotonin receptor blocker, Naftidrofuryl widens blood vessels to improve blood flow and also by allowing the body to make better use of oxygen available in the blood.
Nifedipine is a type of medicine called a calcium-channel blocker. It is sometimes used to treat high blood pressure but it is also a peripheral vasodilator. It works by widening the blood vessels and stopping them from going into a spasm or narrowing.
Moxisylyte is a type of medicine called an alpha-blocker. It works by relaxing the blood vessels, which in turn maintains the supply of blood to the fingers, toes, ears or nose.
Pentoxifylline works by decreasing the thickness of the blood. Blood is then able to flow more easily, especially in the small blood vessels of the hands and feet.
Which peripheral vasodilator is usually prescribed?
Tillbaka till innehållPeripheral arterial disease (PAD):
national guidelines only recommend the use of naftidrofuryl for people with intermittent claudication caused by PAD. Other peripheral vasodilators are not normally prescribed because there is little evidence that any of the others work very well for this condition. However, cilostazol can sometimes be used for the treatment of PAD in selected patients who do not respond to other treatments.
Raynaud's phenomenon:
Nifedipine is recommended to reduce the number and severity of 'vasospastic' attacks - when the blood vessels become narrow (constrict). Other peripheral vasodilators are not normally prescribed, as there is not much evidence to show that they work very well for Raynaud's phenomenon.
Sometimes, if the side-effects of nifedipine cannot be tolerated, a doctor may consider prescribing a different calcium-channel blocker such as nicardipine, amlodipine or felodipine. These medicines are not licensed to treat Raynaud's disease. Rarely, naftidrofuryl or inositol nicotinate may also be prescribed by some doctors to treat Raynaud's phenomenon.
Fortsätt läsa nedan
How should peripheral vasodilators be taken?
Tillbaka till innehållHow nifedipine is taken will depend upon the pattern of symptoms and how well symptoms improve with treatment.
All other vasodilators are taken every day.
What are the possible side-effects?
Tillbaka till innehållMost people who take peripheral vasodilators have no side-effects, or only minor ones. It is not possible in this leaflet to list all the possible side-effects of these medicines. For more detailed information, see the leaflet that comes within the medicine packet.
Nifedipine - some people develop flushing and huvudvärk. Serious side-effects are rare.
Naftidrofuryl - the most commonly reported side-effects are feeling sick, skin rash, stomach pains and runny stools (diarré). On rare occasions, some people taking naftidrofuryl have developed a liver disorder. If any yellowing of the skin or the whites of the eyes is seen, speak with a doctor straightaway.
Cilostazol - the most common side-effects include headache and diarrhoea. Less common side-effects include yrsel, weakness, feeling or being sick, matsmältningsbesvär, tummy (abdominal) pain, fast heartbeat, chest pain, runny nose, bruising, swollen ankles or feet, skin rash and itching.
Inositol nicotinate - side-effects are thought to be uncommon but may include flushing, dizziness, headache, feeling sick, being sick (vomiting), fainting and a rash.
Moxisylyte - the most common side-effects include mild illamående, diarrhoea, dizziness with a spinning sensation (vertigo), headache, facial flushing and a rash. On rare occasions, some people taking moxisylyte have developed a liver disorder. If any yellowing of the skin or the whites of the eyes is seen, speak with a doctor straightaway.
Pentoxifylline - the most common side-effects include nausea, vomiting, and dizziness which may occur. Uncommonly, some people experience a fast or irregular heartbeat.
Other considerations - nifedipine
Tillbaka till innehållDrinking grapefruit juice can interact with nifedipine and alter its effect. Therefore, grapefruit juice should be avoided by anyone taking this particular vasodilator.
Can I buy peripheral vasodilators?
Tillbaka till innehållNo, you cannot buy oral peripheral vasodilators; you need a prescription to obtain these medicines.
Who cannot take peripheral vasodilators?
Tillbaka till innehållMost people are able to take a peripheral vasodilator; however, in some cases these medicines are best avoided.
Nifedipine - should not be given to people who:
Have severe damage to the heart muscle (cardiogenic shock).
Have a valve in the heart that does not open fully (advanced aortic stenosis).
Are within one month of having had a hjärtattack.
Have acute attacks of angina.
Naftidrofuryl - should not be given to people with a history of kidney stones.
Cilostazol - should not be given to people with:
Severe kidney or liver problems.
Uncontrolled högt blodtryck.
A history of having had surgery in the previous three months.
A history of having had a stroke in the previous six months.
Inositol nicotinate - should not be given to people who have had a recent heart attack (myocardial infarction) or stroke.
Moxisylyte - is safe to use in most people.
Pentoxifylline - should not be given to people who have had:
A stroke.
Extensive back of the eye (retinal) bleeding.
A heart attack.
Heart rhythm problems.
For more detailed information, see the leaflet that comes with the medicine packet.
Patient picks for Heart and blood medicines

Behandling och medicinering
Calcium channel blockers
Calcium channel blockers (sometimes called calcium antagonists) are a group of medicines that affect the way calcium passes into certain muscle cells. They are commonly prescribed to manage high blood pressure, angina, Raynaud's phenomenon and some abnormal heart rhythms (arrhythmias). They are also used to try to stop premature labour in pregnancy. A calcium-channel blocker can be used alone. However, one is often combined with another medicine to treat high blood pressure or angina, when one medicine alone has not worked so well.
av Dr Toni Hazell, MRCGP

Behandling och medicinering
Aspirin and other antiplatelet medicines
Most people who have a cardiovascular disease (for example, angina, peripheral arterial disease, or a previous heart attack, transient ischaemic attack (TIA) or stroke) take a low-dose aspirin (75 mg) each day or clopidogrel (75 mg) each day. This reduces the risk of heart attack by about a third. It reduces the risk of having a stroke by about a quarter. A daily low dose of aspirin also reduces the risk of developing a number of common cancers, but it is not advised that everyone in the population should take aspirin for this reason. This is because in some people aspirin can increase the risk of stomach bleeding and stomach ulcers, which are sometimes fatal.
av Dr Toni Hazell, MRCGP

Osäker på att blanda mediciner?
Kontrollera möjliga interaktioner mellan läkemedel, kosttillskott och livsmedel innan du tar dem tillsammans.
Vanliga frågor
Can I take peripheral vasodilators if I'm already taking other medications?
The article mentions that grapefruit juice can interact with nifedipine and alter its effect, so it should be avoided. For information regarding other potential interactions with other medications, you would need to refer to the detailed leaflet that comes with your medicine packet, as this article does not cover all possible interactions.
What should I do if I notice yellowing of my skin or eyes while taking naftidrofuryl or moxisylyte?
On rare occasions, some people taking naftidrofuryl or moxisylyte have developed a liver disorder. If you notice any yellowing of your skin or the whites of your eyes, you should speak with a doctor straightaway.
Are there any alternative treatments for Raynaud's phenomenon if nifedipine isn't suitable for me?
If nifedipine's side-effects cannot be tolerated, a doctor may consider prescribing a different calcium-channel blocker, such as nicardipine, amlodipine, or felodipine. Additionally, in rare cases, naftidrofuryl or inositol nicotinate may also be prescribed by some doctors to treat Raynaud's phenomenon.
How long does it take for peripheral vasodilators to show an improvement in symptoms?
For intermittent claudication, if an improvement in symptoms is not seen within a few weeks, continuing with the medicine is not recommended and stopping treatment would usually be advised. If symptoms improve, treatment can be continued.
Why are some peripheral vasodilators considered ineffective for certain conditions?
For peripheral arterial disease, inositol nicotinate and pentoxifylline are not considered effective. For Raynaud's phenomenon, pentoxifylline and moxisylyte are not considered effective. This is because there is little evidence that these specific drugs work very well for those particular conditions, as stated in the national guidelines and medical evidence.
If I experience a side-effect, what is the 'Yellow Card Scheme' and how do I use it?
The Yellow Card Scheme is a system where you can report any suspected side-effects you experience from medicines or other healthcare products. You can do this online at www.mhra.gov.uk/yellowcard. When reporting, it's helpful to have information about the side-effect, the name of the medicine, details of the person who had the side-effect, and your contact information.
Vidare läsning och referenser
- Lower limb peripheral arterial disease; NICE Clinical Guideline (August 2012, updated December 2020)
- Aboyans V, Ricco JB, Bartelink MEL, et al; 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017 Aug 26. doi: 10.1093/eurheartj/ehx095.
- Su KY, Sharma M, Kim HJ, et al; Vasodilators for primary Raynaud's phenomenon. Cochrane Database Syst Rev. 2021 May 17;5:CD006687. doi: 10.1002/14651858.CD006687.pub4.
- Raynaud's phenomenon; NICE CKS, November 2022 (UK access only)
- Peripheral Arterial Disease; NICE CKS, March 2024 (UK access only)
- Golledge J, Drovandi A; Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease. J Atheroscler Thromb. 2021 Jun 1;28(6):573-583. doi: 10.5551/jat.62778. Epub 2021 Mar 21.
Fortsätt läsa nedan
About the authorView full bio

Dr Surangi Mendis, MRCGP
Consultant and Medical Author
MBBS, BSc (1st), MRCGP (2014), DFSRH, PGcert otology and audiology
Surangi Mendis is a consultant in Audiovestibular Medicine and Neuro-otology at The Royal National ENT and Eastman Dental Hospitals, UCLH.
About the reviewerView full bio

Dr Philippa Vincent, MRCGP
General Practitioner, Medical Author
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dr Philippa Vincent is an NHS GP working in North London.
Artikelhistorik
Informationen på denna sida är skriven och granskad av kvalificerade kliniker.
Nästa granskning: 26 sept 2028
28 sept 2023 | Senaste versionen

Fråga, dela, anslut.
Bläddra i diskussioner, ställ frågor och dela erfarenheter inom hundratals hälsorelaterade ämnen.

Känner du dig sjuk?
Bedöm dina symtom online gratis
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
By subscribing you accept our Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.